Collapsible Language Selector

Translate Page

Monday, February 10, 2025

Sensex Plunges: Top Stocks Bleeding on Tariff Fears

stock market news

Trump's Tariff Scare Spooks Dalal Street: Three Stocks That Bled the Most on Sensex

Dalal Street experienced a wave of selling pressure driven by concerns over potential tariffs, leading to a significant decline on the BSE Sensex. The Sensex closed 548 points lower at 77,311.80, with the majority of its constituent stocks ending the session in the red. Here's a look at the top underperformers:

Top Underperformers on Sensex

Power Grid Corp

  • Decline: Led the losing pack, down nearly 3.27 percent to close at Rs 269.20 apiece.
  • Trading Volume: Saw heavy trading with nearly 3.09 lakh shares, representing over 75 percent of its 10-day average volume.
  • Consecutive Losses: Has seen losses for the fourth consecutive session after reporting a 4 percent decline in Q3 net profit to Rs 3,862 crore.

Tata Steel

  • Decline: Fell over 3 percent to close at Rs 133.90 apiece.
  • Trading Volume: A volume of 11 lakh shares, representing nearly 69 percent of its 10-day average trading volume.
  • Tariff Concerns: Metal stocks faced selling pressure after the threat of a 25 percent tariff on all imports of steel and aluminium into America. Peers like JSW Steel and Hindalco also saw cuts of around 2%.

Zomato

  • Decline: Dropped nearly 3 percent to close at Rs 227.15 apiece.
  • Recent Performance: While recovering from lows earlier this year, it is still 25 percent lower than its all-time high of Rs 304 from December last year.

Titan

  • Decline: Shares fell nearly 2.83 percent to close at Rs 3,327.10 per share.
  • Lowest Level: Currently at its lowest level seen in 200 sessions.

Gainers on Sensex

While the majority of stocks declined, a few traded in the green with minor gains:

  • Kotak Mahindra Bank: Closed 1.34 percent higher at Rs 1,962 per share.
  • Bharti Airtel, HCL Tech, Tech Mahindra, ICICI Bank, and TCS: Recorded minor gains of up to 1 percent.

The market's reaction highlights the sensitivity to global trade developments and their potential impact on specific sectors and companies.

Disclaimer: The views and investment tips expressed in this article are for informational purposes only and do not represent financial advice. The views expressed are those of the sources cited and not necessarily those of this website or its management. Investing in equities or other financial instruments carries the risk of financial loss. Readers must exercise due caution and conduct their own research before making any investment decisions. We are not liable for any losses incurred as a result of decisions made based on this article. Please consult a qualified financial advisor before making any investment.

Reliance Launches 'Spinner' Sports Drink for Rs 10

stock market news

Reliance Retail Launches 'Spinner', a Sports Drink for Just Rs 10

Reliance Consumer Products Limited (RCPL), a subsidiary of Reliance Retail Ventures Limited, has announced the launch of its new sports drink, 'Spinner'. This affordable and refreshing beverage is co-created with the iconic cricketer, Muttiah Muralitharan.

Spinner: Affordable Hydration for All

Spinner is designed to revolutionize hydration by offering a quality sports drink at an accessible price point of just Rs 10. RCPL aims to lead the creation of a sports beverage category worth up to $1 billion in the next 3 years with this uniquely positioned product.

Target Audience

RCPL said Spinner is designed "for every Indian, including fitness enthusiasts, and anyone in need of a quick, effective hydration solution." It is perfect for those working out at the gym or playing sports, helping to replenish lost fluids and electrolytes.

Partnerships and Brand Visibility

Spinner is backed by partnerships with top IPL teams, including:

  • Lucknow Super Giants
  • SunRisers Hyderabad
  • Punjab Kings
  • Gujarat Titans
  • Mumbai Indians

These collaborations will drive awareness and increase brand visibility nationwide.

Muttiah Muralitharan's Endorsement

Muttiah Muralitharan expressed his excitement about the venture, stating, “I am thrilled to be a part of this exciting venture with Reliance Consumer Products. As an athlete, I know how important hydration is... Spinner is a game-changer that will empower every Indian to stay hydrated and active, no matter where they are or what they’re doing.”

Reliance's Vision

Ketan Mody, COO, Reliance Consumer Products Limited, emphasized the company's commitment to providing quality products at affordable prices. "With Spinner, we’ve created an affordable and effective hydration solution that can be enjoyed by everyone...As a total beverage and FMCG company, we are excited to bring this innovative product to the market."

Available Flavors

Spinner is available in three refreshing flavors:

  • Lemon
  • Orange
  • Nitro Blue

Spinner helps replenish what your body loses through sweat, ensuring you stay hydrated and perform at your best.

Disclaimer: The views and investment tips expressed in this article are for informational purposes only and do not represent financial advice. The views expressed are those of the sources cited and not necessarily those of this website or its management. Investing in equities or other financial instruments carries the risk of financial loss. Readers must exercise due caution and conduct their own research before making any investment decisions. We are not liable for any losses incurred as a result of decisions made based on this article. Please consult a qualified financial advisor before making any investment.

Fortis Healthcare Q3 Results: Net Profit Soars 83% YoY

stock market news

Fortis Healthcare in Focus After Reporting 83% YoY Increase in Net Profits

Fortis Healthcare, a leading mid-cap healthcare company with a hospital and diagnostics chain, is gaining attention after reporting its Q3 results, which showcased robust net profit growth and positive performance in both its hospital and diagnostics segments.

Stock Performance

With a market capitalization of Rs. 47,298 Crore, Fortis Healthcare opened at Rs. 662, up 1.89 percent from the previous day's close, also marking the intraday high. The stock has seen a -9 percent return in the past month and an impressive 302 percent return over the past five years.

Q3FY25 Financial Results

  • Revenue: Increased by 14.79 percent YoY, from Rs. 1679.68 Crore in Q3FY24 to Rs. 1928.26 Crore in Q3FY25. However, there was a 3.02 percent QoQ decrease from Rs. 1988.39 Crore in the previous quarter.
  • Net Profit: Surged by 82.74 percent YoY, from Rs. 134.23 Crore to Rs. 254.30 Crore. On a QoQ basis, net profits also increased by 37.70 percent from Rs. 193.08 Crore.
  • Operating Profit Margin: Stood at 19.62 percent for Q3FY25 compared to 17.20 percent for Q3FY24.
  • Net Profit Margin: Reached 11.99 percent, up from 7.54 percent in the same period last year.

Segment Analysis

The company's revenue is primarily derived from two key segments:

  • Healthcare Segment: Accounts for 82.58 percent of total revenue.
  • Diagnostics Segment: Contributes the remaining 17.42 percent.

Operational Highlights

Hospital Business

  • Occupancy Rate: Increased to 67 percent for Q3 FY25, up from 64 percent in Q3 FY24.
  • Average Revenue Per Bed: Increased to Rs. 2.45 Crore/annum, compared to Rs. 2.23 Crore in the same period last year.
  • Average Length of Stay: Slightly decreased to 4.20 Days, compared to 4.32 Days.

The company continued its portfolio rationalization strategy by divesting the business operations of the Richmond Road facility in Bangalore. This is the third divestment, following the Malar facility (Feb’24) and the Vadapalani facility (Jul’23) in Chennai.

Diagnostics Business

  • Operating EBITDA Margin: Increased to 14.4 percent, up from 10 percent in Q3 FY24.
  • Total Tests Conducted: Reached 10.29 Million, compared to 9.85 Million in the same period.

Fortis Healthcare consolidated its stake in Agilus Diagnostics Limited from 57.68 percent to 89.20 percent, utilizing funds from the Rs 1,550 Crore raised through NCDs.

About Fortis Healthcare

Fortis Healthcare Limited, an IHH Healthcare Berhad Company, is a leading integrated healthcare services provider in India. With 27 healthcare facilities, over 4,700 operational beds, and over 405 diagnostics centers, Fortis has a significant presence in India, the United Arab Emirates (UAE), Nepal, and Sri Lanka.

Disclaimer: The views and investment tips expressed in this article are for informational purposes only and do not represent financial advice. The views expressed are those of the sources cited and not necessarily those of this website or its management. Investing in equities or other financial instruments carries the risk of financial loss. Readers must exercise due caution and conduct their own research before making any investment decisions. We are not liable for any losses incurred as a result of decisions made based on this article. Please consult a qualified financial advisor before making any investment.

Chennai Gold Price: Hits Record High Amid Trade War Fears

stock market news

Gold Prices in Chennai Reach Record Highs Amid Global Economic Concerns

Gold prices in Chennai have surged to all-time high levels, driven by intensifying concerns over the U.S. trade situation and escalating global economic uncertainties. Investors are increasingly seeking gold as a safe-haven asset, contributing to the bullish trend.

Key Gold Rate Updates in Chennai

As of today, gold prices in Chennai have climbed for the seventh consecutive trading session:

  • 24K Gold: Reached Rs. 3,900 per 10 grams.
  • 22K Gold: Increased by Rs. 350 per 10 grams, reaching Rs. 79,800.

Silver Prices in Chennai

Silver prices in Chennai have remained relatively stable:

  • Price per Kilogram: Rs. 107,000.
  • Price per 100 Grams: Rs. 10,700 after rising by Rs. 100.

Gold Price Movement in Chennai (Last Five Days)

Gold prices in Chennai have exhibited volatility over the past five days:

  • February 8: 24K - Rs. 87,060, 22K - Rs. 79,450
  • February 7: 24K - Rs. 86,510, 22K - Rs. 79,300
  • February 6: 24K - Rs. 86,510, 22K - Rs. 79,300
  • February 5: 24K - Rs. 86,240, 22K - Rs. 79,300
  • February 4: 24K - Rs. 85,200, 22K - Rs. 78,100

Global Spot Gold and Silver Prices

According to recent reports, global spot gold prices have been on the rise:

  • Spot Gold: Rose 0.5% to USD 2,875.79 per ounce.
  • U.S. Gold Futures: Climbed 0.5% to $2,902.40 per ounce.
  • Spot Silver: Gained 0.6%, trading at $31.99 per ounce.

MCX Gold and Silver Futures Outlook

On the Multi Commodity Exchange (MCX):

  • Gold Futures (April 4, 2025): Jumped by 0.42% to trade at Rs. 85,243.
  • Silver Futures (March 5, 2025): Declined by 0.20%, trading at Rs. 95,146.

Expert Analysis

Experts suggest that global economic uncertainties and geopolitical tensions are driving investors towards gold as a safe haven. The potential for increased tariffs and trade disputes contributes to market volatility, further supporting gold's role as a store of value.

Disclaimer: The views and investment tips expressed in this article are for informational purposes only and do not represent financial advice. The views expressed are those of the sources cited and not necessarily those of this website or its management. Investing in equities or other financial instruments carries the risk of financial loss. Readers must exercise due caution and conduct their own research before making any investment decisions. We are not liable for any losses incurred as a result of decisions made based on this article. Please consult a qualified financial advisor before making any investment.

Eureka Forbes Q3: Net Profit Surges 52.5% to Rs 35 Cr

stock market news

Eureka Forbes Q3 Results: Profit Soars 52.5% to Rs 35 Crore

Eureka Forbes Ltd, a prominent health and hygiene products manufacturer, has announced a significant increase in its consolidated net profit for the December quarter. The company, now under the control of private equity firm Advent International, reported a 52.5% surge in profit.

Key Financial Highlights for Q3

  • Net Profit: Increased to Rs 35.03 crore, a 52.5% rise from Rs 22.97 crore in the same quarter last year.
  • Revenue from Operations: Grew by 10.8% to Rs 597.74 crore, up from Rs 539.43 crore in the corresponding quarter of FY24.
  • Total Income: Rose by 11% to Rs 602.17 crore.

Detailed Analysis of Eureka Forbes' Performance

Profitability

Eureka Forbes' impressive net profit of Rs 35.03 crore demonstrates a substantial improvement compared to the Rs 22.97 crore reported in the same quarter of the previous fiscal year. This growth reflects the company's strong performance in the health and hygiene sector.

Revenue Growth

The company's revenue from operations reached Rs 597.74 crore, showcasing a solid increase compared to Rs 539.43 crore in the corresponding quarter of FY24. This growth is attributed to the increasing demand for Eureka Forbes' health and hygiene products.

Expenses

Eureka Forbes' total expenses climbed by 8.4% to Rs 554.86 crore in the December quarter. This increase is consistent with the company's revenue growth, indicating efficient cost management.

Market Reaction

Shares of Eureka Forbes Ltd were trading at Rs 548.40 apiece on the BSE in the afternoon, up 0.33% from the previous close. This positive market reaction reflects investor confidence in the company's performance and future prospects.

Overall, Eureka Forbes' Q3 results highlight a strong financial performance, driven by significant growth in net profit and revenue. The company's focus on health and hygiene products has positioned it well in the market, contributing to its continued success.

Disclaimer: The views and investment tips expressed in this article are for informational purposes only and do not represent financial advice. The views expressed are those of the sources cited and not necessarily those of this website or its management. Investing in equities or other financial instruments carries the risk of financial loss. Readers must exercise due caution and conduct their own research before making any investment decisions. We are not liable for any losses incurred as a result of decisions made based on this article. Please consult a qualified financial advisor before making any investment.

Hexaware Technologies IPO: 10 Things to Know Before Investing

stock market news

Hexaware Technologies IPO: 10 Key Points Before the ₹8,750 Crore Offer Opens

The initial public offering (IPO) of Hexaware Technologies is set to open for subscription on Wednesday, February 12. Here are 10 key points to consider before investing in this ₹8,750 crore offer.

Key Details of the Hexaware Technologies IPO

  1. Subscription Period: The IPO will be open from February 12 to February 14.
  2. Anchor Investors' Bidding: Bidding for anchor investors opens on February 11.
  3. IPO Offer Structure: The IPO is exclusively an offer for sale (OFS) of 12.36 crore shares.
  4. Price Band: The price range is fixed at ₹674 to ₹708 per equity share.
  5. Reservation:
    • 50% of the net offer is reserved for qualified institutional buyers (QIBs).
    • 35% for retail investors.
    • 15% for non-institutional investors.
  6. Lot Size: Investors can apply for a minimum of 21 shares, requiring an investment of ₹14,868.
  7. Objectives: As it is an OFS, the proceeds will go to the selling shareholders, not the company.
  8. Book-Running Lead Managers: Kotak Mahindra Capital Company Ltd, JP Morgan India Pvt Ltd, HSBC Securities & Capital Markets Pvt Ltd, Citigroup Global Markets India Pvt Ltd and IIFL Securities Ltd.
  9. Registrar: Kfin Technologies Ltd.
  10. Allotment Date: The basis of allotment is expected to be finalized on February 17.
  11. Listing Date: The equity shares will be listed on the BSE and NSE on February 19.

About Hexaware Technologies

Hexaware Technologies provides digital and technological services with artificial intelligence (AI) at its core. It offers innovative solutions to help customers in their digital transformation journey.

Before you invest, make sure you have considered all these key points. The success of this IPO will depend on the market's appetite for technology stocks and investor confidence in Hexaware's future growth prospects.

Disclaimer: The views and investment tips expressed in this article are for informational purposes only and do not represent financial advice. The views expressed are those of the sources cited and not necessarily those of this website or its management. Investing in equities or other financial instruments carries the risk of financial loss. Readers must exercise due caution and conduct their own research before making any investment decisions. We are not liable for any losses incurred as a result of decisions made based on this article. Please consult a qualified financial advisor before making any investment.

Varun Beverages Q4 2024: Revenue Up 38%, Dividend Declared

stock market news

Varun Beverages Q4 Results: Revenue Jumps 38%, Margin Steady at 15.7%

Varun Beverages Ltd., a key bottling partner of PepsiCo Ltd., has released its December quarter results, showcasing substantial revenue growth and consistent profitability. The company follows a calendar year format for reporting earnings.

Key Highlights of Q4 2024 Results

  • Revenue: Increased by 38% year-on-year to ₹3,689 crore.
  • Net Profit: Surged by 40% to ₹185 crore.
  • EBITDA: Rose by 39% to ₹580 crore.
  • EBITDA Margin: Remained flat at 15.7%.

Dividend Announcement

Varun Beverages has recommended a final dividend of ₹0.50 per equity share for the financial year ended December 31, 2024. The record date for the dividend will be determined by the company's Board of Directors in due course.

Volume Growth

The company experienced strong volume growth, with:

  • India Volumes: Growing by 11.4%.
  • Consolidated Volumes: Rising by 23.2%, primarily driven by expansion into new territories.

Strategic Expansion and Acquisitions

Varun Beverages has been actively expanding its geographical presence and product portfolio:

  • New Territories: Entered South Africa and secured distribution rights in Namibia, Botswana, Mozambique, and Madagascar.
  • New Country: Commenced greenfield operations in the Democratic Republic of Congo (DRC).
  • Acquisitions: Entered into a share purchase agreement to acquire PepsiCo’s business in Tanzania and Ghana, pending regulatory approvals.
  • Snacks Business: Forayed into the snacks business with PepsiCo in Morocco, Zimbabwe, and Zambia.

Management Commentary

"We are pleased to conclude CY2024 on a strong note through adding geographical presence into new territories...The growth has been driven by organic volume growth and improved product mix," said Ravi Jaipuria, Chairman – Varun Beverages.

Capital Raising

During the quarter, Varun Beverages successfully raised ₹7,500 crore through a Qualified Institutional Placement (QIP).

Market Reaction

Following the earnings announcement, shares of Varun Beverages Ltd. are trading nearly 2% lower at ₹543.75. The stock is down 16% so far in 2025.

Disclaimer: The views and investment tips expressed in this article are for informational purposes only and do not represent financial advice. The views expressed are those of the sources cited and not necessarily those of this website or its management. Investing in equities or other financial instruments carries the risk of financial loss. Readers must exercise due caution and conduct their own research before making any investment decisions. We are not liable for any losses incurred as a result of decisions made based on this article. Please consult a qualified financial advisor before making any investment.

Nykaa Q3 FY25: Net Profit Jumps 51% to Rs 26 Cr

stock market news

Nykaa Q3 Results: Net Profit Surges 51% to Rs 26 Crore

FSN E-Commerce Ventures, the parent company of the popular beauty and fashion brand Nykaa, has announced its fiscal third-quarter earnings, revealing a strong performance. The company reported a significant 51% year-on-year (Y-o-Y) increase in net profit.

Key Financial Highlights for Q3 FY25

  • Net Profit: Rose to Rs 26.4 crore, compared to Rs 17.5 crore in the same period last year.
  • Consolidated Revenue: Grew by 27% Y-o-Y to Rs 2,267 crore, up from Rs 1,789 crore a year ago.

Detailed Breakdown of Nykaa's Performance

Profitability

Nykaa's impressive net profit of Rs 26.4 crore represents a substantial improvement over the Rs 17.5 crore reported in the year-ago period. The company also saw an increase compared to the previous quarter, where it posted a profit of Rs 13 crore.

Revenue Growth

The company's consolidated revenue from operations reached Rs 2,267 crore, demonstrating strong growth compared to Rs 1,789 crore in the corresponding quarter of the previous fiscal year. It also marks an increase from Rs 1,875 crore in Q2 FY25.

Expenses

Nykaa's total expenses increased in line with revenue growth, reaching Rs 2,228 crore in the December quarter, up from Rs 1,770 crore in the year-ago period. The company reported expenses of Rs 1,859 crore in the previous quarter.

Market Reaction

Ahead of the earnings report, Nykaa's share price experienced a slight decline, sliding 2.3 percent to Rs 169.44 on the NSE at the end of trading on Monday, 10 February.

Overall, Nykaa's Q3 results showcase a robust financial performance, driven by significant growth in net profit and revenue. The company continues to solidify its position in the beauty and fashion market.

Disclaimer: The views and investment tips expressed in this article are for informational purposes only and do not represent financial advice. The views expressed are those of the sources cited and not necessarily those of this website or its management. Investing in equities or other financial instruments carries the risk of financial loss. Readers must exercise due caution and conduct their own research before making any investment decisions. We are not liable for any losses incurred as a result of decisions made based on this article. Please consult a qualified financial advisor before making any investment.